These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12164657)

  • 1. The epidemiology of the oral lesions of HIV infection in the developed world.
    Greenspan JS; Greenspan D
    Oral Dis; 2002; 8 Suppl 2():34-9. PubMed ID: 12164657
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and classification of HIV-associated oral lesions.
    Patton LL; Phelan JA; Ramos-Gomez FJ; Nittayananta W; Shiboski CH; Mbuguye TL
    Oral Dis; 2002; 8 Suppl 2():98-109. PubMed ID: 12164670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of HIV-associated oral lesions and their relation to therapy.
    Birnbaum W; Hodgson TA; Reichart PA; Sherson W; Nittayananta W; Axell TE
    Oral Dis; 2002; 8 Suppl 2():110-4. PubMed ID: 12164643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics.
    Chidzonga MM
    Oral Dis; 2003 Nov; 9(6):317-22. PubMed ID: 14629334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mucosal lesions in a UK HIV/AIDS oral medicine clinic. a nine year, cross-sectional, prospective study.
    Zakrzewska JM; Atkin PA
    Oral Health Prev Dent; 2003; 1(1):73-9. PubMed ID: 15643751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-related oral disease epidemiology among women: year 2000 update.
    Shiboski CH
    Oral Dis; 2002; 8 Suppl 2():44-8. PubMed ID: 12164659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral manifestations of HIV infection: a Panamerican perspective.
    Gillespie GM; Mariño R
    J Oral Pathol Med; 1993 Jan; 22(1):2-7. PubMed ID: 7678293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years.
    Greenwood I; Zakrzewska JM; Robinson PG
    Oral Dis; 2002 Mar; 8(2):90-4. PubMed ID: 11991309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral manifestations of HIV infection in 600 South African patients.
    Arendorf TM; Bredekamp B; Cloete CA; Sauer G
    J Oral Pathol Med; 1998 Apr; 27(4):176-9. PubMed ID: 9563573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, 8-11 February 2004: where are the breakthroughs?
    Mallon PW
    J HIV Ther; 2004 Feb; 9(1):19-22. PubMed ID: 15587480
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral manifestations of HIV/AIDS in clients attending TASO clinics in Uganda.
    Tirwomwe JF; Rwenyonyi CM; Muwazi LM; Besigye B; Mboli F
    Clin Oral Investig; 2007 Sep; 11(3):289-92. PubMed ID: 17476537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing patterns of HIV infection in otolaryngology.
    Birchall MA; Horner PD; Stafford ND
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):473-7. PubMed ID: 7895376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
    Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
    AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups.
    Barone R; Ficarra G; Gaglioti D; Orsi A; Mazzotta F
    Oral Surg Oral Med Oral Pathol; 1990 Feb; 69(2):169-73. PubMed ID: 2304743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts.
    Feigal DW; Katz MH; Greenspan D; Westenhouse J; Winkelstein W; Lang W; Samuel M; Buchbinder SP; Hessol NA; Lifson AR
    AIDS; 1991 May; 5(5):519-25. PubMed ID: 1863403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral manifestations associated with human immunodeficiency virus infection in a Spanish population.
    Ceballos-Salobreña A; Aguirre-Urizar JM; Bagan-Sebastian JV
    J Oral Pathol Med; 1996 Nov; 25(10):523-6. PubMed ID: 8986962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary profile of oral manifestations of HIV/AIDS and associated risk factors in a Southeastern US clinic.
    Tamí-Maury I; Willig J; Vermund S; Jolly P; Aban I; Hill J; Wilson CM
    J Public Health Dent; 2011; 71(4):257-64. PubMed ID: 22320283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral lesions in HIV infection in developing countries: an overview.
    Ranganathan K; Hemalatha R
    Adv Dent Res; 2006 Apr; 19(1):63-8. PubMed ID: 16672552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy.
    Schmidt-Westhausen AM; Priepke F; Bergmann FJ; Reichart PA
    J Oral Pathol Med; 2000 Aug; 29(7):336-41. PubMed ID: 10947250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.